Canada markets close in 5 hours 29 minutes

Recce Pharmaceuticals Ltd (RCE.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.5950+0.0150 (+2.59%)
At close: 03:59PM AEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Operating Expenses
Selling General and Administrative
5,329
5,231
3,367
7,509
1,587
Total Operating Expenses
17,639
17,243
12,597
15,200
5,260
Operating Income or Loss
-17,639
-17,243
-12,597
-15,200
-5,260
Interest Expense
434.908
172.623
2.416
2.107
45.847
Total Other Income/Expenses Net
6,708
4,282
1,532
1,593
974.23
Income Before Tax
-11,317
-13,077
-10,986
-13,513
-4,317
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-11,317
-13,077
-10,986
-13,513
-4,317
Net Income
-11,317
-13,077
-10,986
-13,513
-4,317
Net Income available to common shareholders
-11,317
-13,077
-10,986
-13,513
-4,317
Basic EPS
-0.07
-0.07
-0.06
-0.09
-0.03
Diluted EPS
-0.07
-0.07
-0.06
-0.09
-0.03
Basic Average Shares
175,714
175,714
175,871
156,955
128,477
Diluted Average Shares
175,714
175,714
175,871
156,955
128,477